Scientists Discover Why Appetite Vanishes During Illness Through Gut-Brain Communication

Scientists have identified the molecular pathway through which the body suppresses appetite during illness, resolving a question that has puzzled physicians and biologists for generations: why do sick people so reliably lose their desire to eat even when their bodies most need energy to fight infection? Researchers at the Salk Institute for Biological Studies found that inflammatory signals released by the immune system during infection directly activate a specific population of neurons in the gut lining that then relay suppression signals to the brain through the vagus nerve — a dedicated communication line between the digestive system and the central nervous system that has only recently been understood as a major regulator of appetite and mood.

The study, published in the journal Cell, used a combination of genetic tools and targeted neuron silencing in mice to trace the appetite suppression signal from its origin in immune-activated gut cells all the way to its endpoint in the hypothalamus, the brain region that regulates hunger. The key molecular messenger turned out to be prostaglandin E2, an inflammatory lipid compound that is produced during infection and normally associated with fever and pain. The researchers found that gut-lining cells called enterochromaffin cells have receptors specifically tuned to prostaglandin E2, and that when those cells detect the inflammatory signal, they release serotonin onto vagal nerve fibers that carry the 'stop eating' signal to the brain within minutes.

'This is fundamentally a protective mechanism,' said Dr. Yin Chen, the paper's senior author. 'When you're fighting a serious infection, digesting a large meal competes with your immune response for metabolic resources. The body has a very sophisticated circuit that says: this is not the time. Redirect your energy.' The researchers showed that mice genetically engineered to lack the prostaglandin E2 receptor on enterochromaffin cells continued eating normally even when injected with bacterial toxins that would normally cause complete appetite suppression in healthy animals — confirming that the pathway is both necessary and sufficient for illness-related anorexia.

The discovery has potentially significant clinical implications, particularly for cancer patients undergoing chemotherapy, which triggers intense inflammation and often causes treatment-limiting appetite loss and weight decline. Current antiemetic drugs target nausea pathways but do not address the deeper appetite suppression mechanism the new research identifies. A drug that specifically blocked prostaglandin E2 signaling in gut enterochromaffin cells — without broadly suppressing inflammation throughout the body, which would interfere with immune function — could help patients maintain the nutritional intake necessary to tolerate treatment. The researchers said they were already collaborating with a pharmaceutical partner to screen compounds that might achieve this targeted effect.

The vagus nerve pathway identified in the study is part of what researchers call the gut-brain axis, a bidirectional communication system that has emerged over the past decade as a major area of biomedical investigation. Previous work has shown that gut microbiome composition can influence mood and anxiety through vagal signaling, and that the vagus nerve plays a role in regulating inflammation throughout the body. The new findings add appetite regulation during immune activation to the growing list of physiological functions mediated through this pathway. 'We tend to think of appetite as being controlled by the brain, by hormones, by willpower,' said Dr. Diego Bohórquez of Duke University, an expert on gut-brain communication who was not involved in the study. 'What this paper shows is that your gut is actively and directly talking to your brain about the state of your immune system in real time.'